Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aripiprazole”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00857818
What this trial is testing

Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar I Disorder+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 64
Large-scale testing (Phase 3)Not Yet RecruitingNCT07153406
What this trial is testing

Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients

Who this might be right for
Depressive Disorder
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 220
Large-scale testing (Phase 3)WithdrawnNCT00276978
What this trial is testing

Aripiprazole Augmentation Therapy in Treatment-resistant Depression

Who this might be right for
Therapy-resistant Depression
University Hospital Freiburg
Post-approval studies (Phase 4)UnknownNCT04234776
What this trial is testing

Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression

Who this might be right for
Depressive Disorder
University of Sao Paulo 88
Not applicableEnded earlyNCT00282139
What this trial is testing

Aripiprazole in the Treatment of Tourette's Syndrome

Who this might be right for
Tourette's Syndrome
University of Florida 40
Post-approval studies (Phase 4)Study completedNCT00328367
What this trial is testing

Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia

Who this might be right for
Schizophrenia
Seoul National University Hospital 61
Post-approval studies (Phase 4)Study completedNCT00224822
What this trial is testing

The Effects of Aripiprazole on Patients With Metabolic Syndrome

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+1 more
New Mexico VA Healthcare System 27
Post-approval studies (Phase 4)Study completedNCT01161277
What this trial is testing

Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning

Who this might be right for
PsychosisSchizophrenia
Oslo University Hospital 54
Post-approval studies (Phase 4)Study completedNCT00095810
What this trial is testing

Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

Who this might be right for
Parkinson's DiseasePsychoses
Otsuka Pharmaceutical Development & Commercialization, Inc. 50
Post-approval studies (Phase 4)Study completedNCT00250705
What this trial is testing

Trial of Aripiprazole in the Treatment of CD in Adolescents

Who this might be right for
Conduct Disorder
University of Iowa 12
Post-approval studies (Phase 4)Study completedNCT00223496
What this trial is testing

12- Week Open Label Treatment of Refractory Bipolar Depression

Who this might be right for
Bipolar Disorder
The University of Texas Health Science Center at San Antonio 32
Post-approval studies (Phase 4)UnknownNCT03090503
What this trial is testing

Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up

Who this might be right for
SchizophreniaPsychotic DisordersPsychosis
Fundación Marques de Valdecilla 200
Large-scale testing (Phase 3)Study completedNCT03345979
What this trial is testing

Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Alkermes, Inc. 200
Not applicableStudy completedNCT03919994
What this trial is testing

Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

Who this might be right for
Schizophrenia
Alkermes, Inc. 338
Post-approval studies (Phase 4)Study completedNCT02404532
What this trial is testing

Substudy 'B' of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)

Who this might be right for
Device Latency
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Large-scale testing (Phase 3)Ended earlyNCT02168920
What this trial is testing

Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Co., Ltd. 150
Large-scale testing (Phase 3)Study completedNCT01942161
What this trial is testing

A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Co., Ltd. 106
Post-approval studies (Phase 4)UnknownNCT02069977
What this trial is testing

Study to Evaluate the Efficacy and Safety of Aripiprazole

Who this might be right for
Autism
Yoo-Sook Joung 79
Post-approval studies (Phase 4)UnknownNCT06060886
What this trial is testing

Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis

Who this might be right for
SchizophreniaTreatment-resistant SchizophreniaSide Effect+4 more
Consorcio Centro de Investigación Biomédica en Red (CIBER) 244
Testing effectiveness (Phase 2)UnknownNCT00737256
What this trial is testing

A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence

Who this might be right for
SchizophreniaCocaine Dependence
Paul Saenger 44
Next Page